Literature DB >> 35601022

Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.

Mitra Abbasifard1,2, Mohammad Kazemi Arababadi1,3, Fatemeh Bahrehmand2,4, Gholamreza Bazmandegan4,5, Ziba Shabani Shahrbabaki1,2, Zahra Kamiab4,5.   

Abstract

Cytokine storm is a main complication in the hospitalized patients, who are infected with the novel coronavirus (COVID-19). The pro-inflammatory cytokines are the main causes of the cytokine storm, however, the roles played by IL-17A, IL-23 and CCL3 are yet to be clarified completely. This prospective study was aimed to explore serum levels of these cytokines in the hospitalized patients infected by COVID-19. Serum levels of IL-17A, IL-23 and CCL3 were measured in 30 COVID-19 infected patients in parallel with 30 healthy controls using ELISA technique. Although serum levels of IL-17A, IL-23 and CCL3 did not alter in the patients in comparison to healthy controls, male patients had higher serum levels of IL-23 than women. Hypertension, type 2 diabetes, lung involvement and age did not affect serum levels of IL-17A, IL-23 and CCL3 in the patients. It appears that IL-17A, IL-23 and CCL3 do not participate in the pro-inflammatory responses in Iranian hospitalized COVID-19 infected patients. However, the gender can be considered as a risk factor for production of more IL-23, which needs to be explored further. AJCEI
Copyright © 2022.

Entities:  

Keywords:  CCL3; COVID-19; IL-17A; IL-23; inflammation

Year:  2022        PMID: 35601022      PMCID: PMC9123428     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  18 in total

Review 1.  Regulation of Memory T Cells by Interleukin-23.

Authors:  Yanchun Li; Hongbo Wang; Honghua Lu; Shucheng Hua
Journal:  Int Arch Allergy Immunol       Date:  2016-04-22       Impact factor: 2.749

2.  IL-23 promotes tumour incidence and growth.

Authors:  John L Langowski; Xueqing Zhang; Lingling Wu; Jeanine D Mattson; Taiying Chen; Kathy Smith; Beth Basham; Terrill McClanahan; Robert A Kastelein; Martin Oft
Journal:  Nature       Date:  2006-05-10       Impact factor: 49.962

Review 3.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis.

Authors:  Antonella Di Cesare; Paola Di Meglio; Frank O Nestle
Journal:  J Invest Dermatol       Date:  2009-03-26       Impact factor: 8.551

Review 4.  IL-17A in hepatitis B infection: friend or foe?

Authors:  Mohammad Kazemi Arababadi; Mohammad Zare Bidaki; Derek Kennedy
Journal:  Arch Virol       Date:  2014-02-18       Impact factor: 2.574

5.  Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells.

Authors:  Helen K W Law; Chung Yan Cheung; Hoi Yee Ng; Sin Fun Sia; Yuk On Chan; Winsie Luk; John M Nicholls; J S Malik Peiris; Yu Lung Lau
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

Review 6.  COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.

Authors:  Long-Quan Li; Tian Huang; Yong-Qing Wang; Zheng-Ping Wang; Yuan Liang; Tao-Bi Huang; Hui-Yun Zhang; Weiming Sun; Yuping Wang
Journal:  J Med Virol       Date:  2020-03-23       Impact factor: 2.327

7.  Potential role of IL-17 blocking agents in the treatment of severe COVID-19?

Authors:  Vedrana Bulat; Mirna Situm; Marija Delas Azdajic; Robert Likic
Journal:  Br J Clin Pharmacol       Date:  2020-07-05       Impact factor: 3.716

Review 8.  Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Authors:  Bingwen Liu; Min Li; Zhiguang Zhou; Xuan Guan; Yufei Xiang
Journal:  J Autoimmun       Date:  2020-04-10       Impact factor: 7.094

9.  Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.

Authors:  Zhaohai Zheng; Fang Peng; Buyun Xu; Jingjing Zhao; Huahua Liu; Jiahao Peng; Qingsong Li; Chongfu Jiang; Yan Zhou; Shuqing Liu; Chunji Ye; Peng Zhang; Yangbo Xing; Hangyuan Guo; Weiliang Tang
Journal:  J Infect       Date:  2020-04-23       Impact factor: 6.072

Review 10.  COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.

Authors:  Michael P Schön; Carola Berking; Tilo Biedermann; Timo Buhl; Luise Erpenbeck; Kilian Eyerich; Stefanie Eyerich; Kamran Ghoreschi; Matthias Goebeler; Ralf J Ludwig; Knut Schäkel; Bastian Schilling; Christoph Schlapbach; Georg Stary; Esther von Stebut; Kerstin Steinbrink
Journal:  J Dtsch Dermatol Ges       Date:  2020-08-06       Impact factor: 5.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.